Menthol-Modified Quercetin Liposomes with Brain-Targeting Function for the Treatment of Senescent Alzheimer's Disease

被引：3

作者：

Liu, Wan-ying ^{[1
]}

Yu, Yang ^{[1
]}

Zang, Juan ^{[1
]}

Liu, Yang ^{[1
]}

Li, Feng-rui ^{[1
]}

Zhang, Lu ^{[1
]}

Guo, Rui-bo ^{[1
]}

Kong, Liang ^{[1
]}

Ma, Ling-yue ^{[2
]}

Li, Xue-tao ^{[1
]}

机构：

[1] Liaoning Univ Tradit Chinese Med, Sch Pharm, Dalian 116600, Peoples R China

[2] Peking Univ First Hosp, Dept Pharm, Beijing 100034, Peoples R China

来源：

ACS CHEMICAL NEUROSCIENCE | 2024年 / 15卷 / 11期

基金：

中国博士后科学基金;

关键词：

quercetin; menthol; blood-brain barrier; aging; Alzheimer's disease; BARRIER; INFLAMMATION; BDNF;

D O I：

10.1021/acschemneuro.4c00109

中图分类号：

Q5 [生物化学]; Q7 [分子生物学];

学科分类号：

071010 ; 081704 ;

摘要：

Oxidative stress and neuroinflammation in the aging brain are correlated with the development of neurodegenerative diseases, such as Alzheimer's disease (AD). The blood-brain barrier (BBB) poses a significant challenge to the effective delivery of therapeutics for AD. Prior research has demonstrated that menthol (Men) can augment the permeability of the BBB. Consequently, in the current study, we modified Men on the surface of liposomes to construct menthol-modified quercetin liposomes (Men-Qu-Lips), designed to cross the BBB and enhance quercetin (Qu) concentration in the brain for improved therapeutic efficacy. The experimental findings indicate that Men-Qu-Lips exhibited good encapsulation efficiency and stability, successfully crossed the BBB, improved oxidative stress and neuroinflammation in the brains of aged mice, protected neurons, and enhanced their learning and memory abilities.

引用

页码：2283 / 2295

页数：13

共 50 条

[21] Effects of The Dietary Flavonoid Quercetin on Brain Inflammation in Alzheimer'S Disease
Jung, Seung H.
Murphy, E. Angela
McClellan, Jamie L.
Carmichael, Martin D.
Davis, J. Mark
MEDICINE AND SCIENCE IN SPORTS AND EXERCISE, 2010, 42 (05): : 45 - 45
[22] Potentiality of phosphatidylserine (PS)-liposomes for treatment of Alzheimer's disease
Hashioka, S
Monji, A
Han, YH
Nakanishi, H
Kanba, S
JOURNAL OF NEUROIMMUNOLOGY, 2004, 154 (1-2) : 119 - 119
[23] Quercetin-modified gold-palladium nanoparticles as a potential autophagy inducer for the treatment of Alzheimer's disease
Liu, Yanan
Zhou, Hui
Yin, Tiantian
Gong, Youcong
Yuan, Guanglong
Chen, Lanmei
Liu, Jie
JOURNAL OF COLLOID AND INTERFACE SCIENCE, 2019, 552 : 388 - 400
[24] Targeting Estrogen Receptors for the Treatment of Alzheimer's Disease
Lee, Jung Hoon
Jiang, Yanxialei
Han, Dong Hoon
Shin, Seung Kyun
Choi, Won Hoon
Lee, Min Jae
MOLECULAR NEUROBIOLOGY, 2014, 49 (01) : 39 - 49
[25] Targeting neuroinflammation in the treatment and prevention of Alzheimer's disease
Zenaro, E.
Constantin, G.
DRUGS OF THE FUTURE, 2017, 42 (01) : 21 - 42
[26] Targeting the hematopoietic system for the treatment of Alzheimer's disease
Lampron, Antoine
Gosselin, David
Rivest, Serge
BRAIN BEHAVIOR AND IMMUNITY, 2011, 25 : S71 - S79
[27] Targeting Estrogen Receptors for the Treatment of Alzheimer’s Disease
Jung Hoon Lee
Yanxialei Jiang
Dong Hoon Han
Seung Kyun Shin
Won Hoon Choi
Min Jae Lee
Molecular Neurobiology, 2014, 49 : 39 - 49
[28] Targeting Insulin Signaling for the Treatment of Alzheimer's Disease
Chen, Yanxing
Zhang, Jianfang
Zhang, Baorong
Gong, Cheng-Xin
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2016, 16 (05) : 485 - 492
[29] Targeting APP metabolism for the treatment of Alzheimer's disease
Sambamurti, K
Hardy, J
Refolo, LM
Lahiri, DK
DRUG DEVELOPMENT RESEARCH, 2002, 56 (02) : 211 - 227
[30] Cholesterol's Function and Origin in the Alzheimer's Disease Brain
Hansen, Scott B.
JOURNAL OF ALZHEIMERS DISEASE, 2023, 94 (02) : 471 - 472

← 1 2 3 4 5 →